Welcome to our dedicated page for Earth Science Te news (Ticker: ETST), a resource for investors and traders seeking the latest updates and insights on Earth Science Te stock.
Earth Science Tech, Inc. reports news on its role as a diversified healthcare and wellness holding company with OTC-traded common stock. Recurring updates cover its compounding pharmacy operations, including RxCompoundStore.com and Mister Meds, and telemedicine platforms such as Peaks Curative, DOConsultation, MOCTeledoc and MyOnlineConsultation.com.
Company announcements also address financial results, public-company governance, auditor and investor-relations changes, industry-classification updates, FINRA quotation clearance, and portfolio activity outside healthcare through Avenvi real estate and asset management and MagneChef direct-to-consumer products.
Earth Science Tech (OTC:ETST)/b) announced that CEO and Chairman Giorgio R. Saumat will present at the .
The presentation is scheduled for Wednesday, June 17, 2026, at 9:00 a.m. PT / 12:00 p.m. ET at the Bellagio Resort & Hotel and will include a live Q&A and one-on-one investor meetings.
Earth Science Tech (OTC: ETST) launched MyOnlineConsultation.com via MOCTeledoc, LLC, completing a vertically integrated telehealth-to-pharmacy ecosystem on March 24, 2026.
MOCTeledoc exited beta as cash-flow-positive and management projects it will become a meaningful revenue stream alongside ETST's compounding and DTC divisions, which reported $25.9 million revenue for the nine months ended December 31, 2025.
Earth Science Tech (OTC: ETST) announced strategic portfolio, governance and capital-discipline initiatives aimed at positioning the company as an institutional-ready public company.
Management reported $3.3M net income for fiscal 2025 and expects approximately $1.4M in annualized cost savings for fiscal 2026, supporting an anticipated ~40%+ net income increase to $4.7M on a go-forward basis.
Key steps include divesting non-core assets, consolidating subsidiaries, introducing advisory shareholder votes (including say-on-pay and Series B retirement), executives voiding employment contracts to reduce costs, and reduced board compensation.
Earth Science Tech (OTC: ETST) engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor on Feb. 17, 2026 to upgrade audit capabilities and governance.
The company cited rising consolidated accounting complexity across pharmacy compounding, telemedicine and real estate and said the regional firm’s broader resources and specialized expertise will optimize auditing efficiencies and better match ETST’s current operational scale.
Earth Science Tech (OTC: ETST) reported Q3 fiscal 2026 results for the quarter ended December 31, 2025, with revenue of $8.4M (+14.1% YoY) and net income of $910K (+341% YoY). Gross profit rose $1.3M to $6.4M (76.3% margin). Adjusted EBITDA was $1.2M. Cash on hand fell to $416K as inventory and operations increased. The company reported Peaks telemedicine revenue surpassing $2.0M in under a year and repurchased shares during the period.
Earth Science Tech (OTC: ETST) will release financial results for the three months ended December 31, 2025 after the close of trading on Tuesday, February 17, 2026. Investors may submit questions in advance and listen via conference call or live webcast.
Conference call is scheduled for 5:00 p.m. Eastern on February 17, 2026, with toll‑free and international dial‑in numbers, passcode, and replay webcast links provided for investor access.
Earth Science Tech (OTC: ETST) issued a directive on Jan 6, 2026 asking financial data providers, news aggregators, and brokerages to update its SEC-registered industry classification to SIC 2834 (Pharmaceutical Preparations).
The company says it completed a strategic pivot to pharmaceutical operations in 2022, operates pharmaceutical compounding and telemedicine businesses (RxCompoundStore.com, Mister Meds, Peaks Curative, DOConsultations), and reports that clearance of its 15c-211 was the final regulatory step to establish ETST as a pharmaceutical entity. ETST provided its SEC CIK 0001538495 and is engaging major data desks to remove legacy CBD/cannabis tags.
Earth Science Tech (OTC: ETST) engaged Hayden IR on Jan 5, 2026 to expand investor outreach, messaging, and market awareness after completing FINRA 15c-211 clearance. Hayden IR will support institutional and retail outreach, corporate access, and public disclosure support as ETST scales operations across pharmacy, telemedicine, and direct-to-consumer channels.
Management highlighted first-half fiscal 2026 results of $17.8M revenue, $1.4M net income, $1.18M operating cash flow, and gross margins >70%; Hayden IR cited operating leverage and CEO alignment (over 122M shares held).
Earth Science Tech (OTC: ETST) announced that the Financial Industry Regulatory Authority processed a Form 211 filed by a sponsoring broker-dealer on Dec 12, 2025, clearing the broker-dealer to initiate priced quotations for ETST within four days of Dec 12, 2025. The company described this clearance as a strategic milestone expected to help build long-term shareholder value, improve liquidity, and increase visibility for its business plan. The release notes that FINRA's processing of Form 211 does not constitute FINRA approval of the security, the issuer, or the issuer's business and relates solely to the broker-dealer's compliance with applicable FINRA and SEC rules.
Earth Science Tech (OTC: ETST) reported strong Second Fiscal Quarter results for the period ended September 30, 2025. Key financials: Total Assets $8.66M (+71.64% YoY, +22.65% YTD from $7.07M), Quarterly Revenue $9.05M (+6.24%), Gross Profit $6.72M (+7.3%), and Quarterly Net Profit $0.94M (+18.48%). Outstanding common shares fell to 292.8M, a 3.57% reduction YoY. Management described the quarter as execution of its strategy to acquire and scale high-potential operating businesses and cited asset growth and share reduction as evidence of shareholder-value focus.